Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy
Angewandte Chemie International Edition · 06.03.2023 · 62 (11)
DOI: 10.1002/anie.202218128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 06.02.2023. Verfasst von Wen Su und 10 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience an…. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Neoplasms. Die Arbeit wurde bisher 136-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
Proteolysis targeting chimeras (PROTACs) technology is an emerging approach to degrade disease‐associated proteins. Here, we report carbon‐dot (CD)‐based PROTACs (CDTACs) that degrade membrane proteins via the ubiquitin‐proteasome system. CDTACs can bind to programmed cell death ligand 1 (PD‐L1), recruit cereblon (CRBN) to induce PD‐L1 ubiquitination, and degrade them with proteasomes. Fasting‐mimicking diet (FMD) is also used to enhance the cellular uptake and proteasome activity. More than 99 % or 90 % of PD‐L1 in CT26 or B16‐F10 tumor cells can be degraded by CDTACs, respectively. Furthermore, CDTACs can activate the stimulator of interferon genes (STING) pathway to trigger immune responses. Thus, CDTACs with FMD treatment effectively inhibit the growth of CT26 and B16‐F10 tumors. Compared with small‐molecule‐based PROTACs, CDTACs offer several advantages, such as efficient membrane protein degradation, targeted tumor accumulation, immune system activation, and in vivo detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
- Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
- School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China.
ORCID-Profile: Hai Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Postdoctoral Research Foundation of China
Zitieren
APA
Su, W., Tan, M., Wang, Z., Zhang, J., Huang, W., Song, H., Wang, X., Ran, H., Gao, Y., Nie, G., & Wang, H. (2023). Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy. Angewandte Chemie International Edition, 62(11). https://doi.org/10.1002/anie.202218128
Vancouver
Su W, Tan M, Wang Z, Zhang J, Huang W, Song H, et al. Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy. Angewandte Chemie International Edition. 2023;62(11). doi:10.1002/anie.202218128
BibTeX
@article{Su2023,
author = {Su, Wen and Tan, Mixiao and Wang, Zhihang and Zhang, Jie and Huang, Wenping and Song, Haohao and Wang, Xinye and Ran, Haitao and Gao, Yanfeng and Nie, Guangjun and Wang, Hai},
title = {Targeted Degradation of PD‐L1 and Activation of the STING Pathway by Carbon‐Dot‐Based PROTACs for Cancer Immunotherapy},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {11},
doi = {10.1002/anie.202218128}
}
EUVIMED